Raymond James raises Allstate target to $300
Raymond James analyst C. Gregory Peters maintained a Strong Buy rating on Allstate and raised the price target to $300 from $260, signaling confidence in the insurer's valuation. This follows a separate update from Morgan Stanley, which maintained an Equal-Weight rating and raised its target to $240.
*this image is generated using AI for illustrative purposes only.
Raymond James analyst C. Gregory Peters has maintained a Strong Buy rating on Allstate (NYSE: ALL) and raised the price target to $300 from $260. The adjustment signals increased confidence in the insurer's valuation and potential for market outperformance. This development follows a recent revision by Morgan Stanley, which maintained an Equal-Weight rating with a price target of $240.
Rating and Target Details
The Strong Buy rating indicates that Allstate's stock is expected to significantly outperform the broader market. The increased price target reflects a more bullish stance on the company's future upside compared to previous estimates.
| Firm | Rating | Previous Price Target | New Price Target |
|---|---|---|---|
| Raymond James | Strong Buy | $260 | $300 |
| Morgan Stanley | Equal-Weight | $215 | $240 |
Allstate continues to be monitored for its operational performance and market position within the insurance sector.
What specific operational metrics or market conditions drove Raymond James to increase their price target by 15%?
How will Allstate's capital allocation strategy, including share buybacks or dividends, evolve to support this higher valuation?
What are the potential risks to Allstate's profitability from rising inflation and climate-related claims in the coming quarters?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
